Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-01-22 Purchase | 2021-01-22 4:26 pm | Prevail Therapeutics Inc. | PRVL | Tyto Acquisition Corp ELI LILLY & Co 10% Owner | 34,284,789 | $22.5 | $771,407,753 | 100 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-01-22 Equity Swap | 2021-01-26 5:20 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC Director 10% Owner | 13,822,463 | $0 | 0 (Indirect) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:19 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 2,385,756 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:19 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 1,757,900 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:18 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Adams Timothy M Director | 49,400 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:17 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Carson William H. Director | 34,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:16 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Dai Yong Chief Technology Officer | 370,239 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:15 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Hefti Franz Chief Development Officer | 388,939 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:14 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Kaplan Brett Chief Financial Officer | 506,569 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:13 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:13 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 416,749 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:12 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 23,747 | $0 | 0 (Indirect) | View |
| 2021-01-22 Disposition | 2021-01-26 5:12 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 182,447 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:11 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Schwartz Kira M. General Counsel | 100,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:09 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Sevigny Jeffrey Chief Medical Officer | 611,781 | $0 | 0 (Direct) | View |
| 2021-01-22 Disposition | 2021-01-26 5:08 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Sheng Morgan Director | 37,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:07 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nussbaum Ran Director | 1,576,881 | $0 | 0 (Indirect) | View |
| 2021-01-22 Disposition | 2021-01-26 5:07 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Nussbaum Ran Director | 17,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:06 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner | 13,822,463 | $0 | 0 (Indirect) | View |
| 2021-01-22 Disposition | 2021-01-26 5:06 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner | 17,000 | $0 | 0 (Direct) | View |
| 2021-01-22 Equity Swap | 2021-01-26 5:05 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner | 13,822,463 | $0 | 0 (Indirect) | View |
| 2021-01-22 Disposition | 2021-01-26 5:05 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner | 17,000 | $0 | 0 (Direct) | View |
| 2020-12-30 Exercise | 2020-12-31 4:54 pm | N/A 2028-03-05 | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 125,793 | $0 | 3,893,656 (Direct) | View |
| 2020-12-30 Exercise | 2020-12-31 4:54 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 5,256 | $0.18 | 3,893,656 (Direct) | View |
| 2020-12-30 Tax Withholding | 2020-12-31 4:54 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 89,037 | $23.02 | 3,893,656 (Direct) | View |
| 2020-12-30 Exercise | 2020-12-31 4:54 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO | 120,537 | $10.26 | 3,893,656 (Direct) | View |
Ownership | 2020-12-16 8:07 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Tyto Acquisition Corp ELI LILLY & Co 10% Owner | 0 | $0 | 0 (Direct) | View |
| 2020-09-09 Option Award | 2020-09-11 08:30 am | N/A 2030-09-09 | Prevail Therapeutics Inc. | PRVL | Carson William H. Director | 34,000 | $0 | 34,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:40 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Thompson Peter A. Director 10% Owner | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:39 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Sheng Morgan Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:38 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Nussbaum Ran Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:37 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | GORDON CARL L Director 10% Owner | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:37 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Adams Timothy M Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 6:36 pm | N/A 2030-06-17 | Prevail Therapeutics Inc. | PRVL | Nader Francois Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-06-02 Option Award | 2020-06-03 6:43 pm | N/A 2030-06-02 | Prevail Therapeutics Inc. | PRVL | Schwartz Kira M. General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:54 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Dai Yong Chief Technology Officer | 43,500 | $0 | 43,500 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:53 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Hefti Franz Chief Development Officer | 62,200 | $0 | 62,200 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:52 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 54,000 | $0 | 54,000 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:51 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Kaplan Brett Chief Financial Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:50 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Abeliovich Asa President & CEO 10% Owner | 250,000 | $0 | 250,000 (Direct) | View |
| 2020-02-19 Option Award | 2020-03-11 4:49 pm | N/A 2030-02-19 | Prevail Therapeutics Inc. | PRVL | Sevigny Jeffrey Chief Medical Officer | 89,000 | $0 | 89,000 (Direct) | View |
| 2019-12-24 Exercise | 2020-03-11 4:47 pm | N/A 2027-10-24 | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0 | 162,000 (Direct) | View |
| 2019-12-24 Exercise | 2020-03-11 4:47 pm | N/A N/A | Prevail Therapeutics Inc. | PRVL | Minkow Emily Chief Business Officer | 13,000 | $0.18 | 162,000 (Direct) | View |